ZhaoQ, PotterCS, CarragherB, et al.Characterization of virus-like particles in GARDASIL(R) by cryo transmission electron microscopy. Hum. Vaccin. Immunother. 2014; 10(3): 734–739. DOI: 10.4161/hv.27316.
5.
ScapinG, PotterCS, Carragher, et al.Cryo-EM for small molecules discovery, design, understanding and application. Cell Chem. Biol., 2018; 25(11): 1318–1325. DOI: 10.1016/j.chembiol.2018.07.006.
6.
GreberBJ, RemisJ, AliS, et al.2.5 Å-resolution structure of human CDK-activating kinase bound to the clinical inhibitor ICEC0942. Biophys. J., 2021; 120(4): 677–686. DOI: 10.1016/j.bpj.2020.12.030.
7.
YinW, MaoC, LuanX, et al.Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science, 2022; 368(6498): 1499–1504. DOI: 10.1126/science.abc1560.
8.
Cambridge Pharmaceutical Cryo-EM Consortium formed by FEI, five pharmaceutical companies, the Medical Research Council and the University of Cambridge. News Medical Life Sciences. Published April4, 2016. Accessed October 25, 2022.
9.
SaurM, HartshornMJ, DongJ, et al.Fragment-based drug discovery using cryo-EM. Drug Discov. Today, 2020; 25(3): 485–490. DOI: 10.1016/j.drudis.2019.12.006.
10.
VelasquezF. What is cryo-EM and how to choose the best storage for it?. Quo-byte. Published September26, 2022. Accessed October 25, 2022.
11.
DrulyteL, KoesterS, LundbergD, et al.High-throughput cryo-EM epitope mapping of SARS-CoV-2 spike protein antibodies using EPU Multigrid. Thermo Fisher Scientific White Paper. 2022.